Walgreens Price Target Increased to $50.00 by Analysts at Guggenheim (WAG)
Walgreens (NYSE: WAG) traded down 0.15% on Wednesday, hitting $45.953. Walgreens has a 52-week low of $28.53 and a 52-week high of $46.33. The stock’s 50-day moving average is currently $41.48. The company has a market cap of $43.430 billion and a price-to-earnings ratio of 20.82.
Walgreens (NYSE: WAG) last released its earnings data on Tuesday, March 19th. The company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.02. The company had revenue of $18.65 billion for the quarter, compared to the consensus estimate of $18.72 billion. During the same quarter in the prior year, the company posted $0.78 earnings per share. The company’s quarterly revenue was up .0% on a year-over-year basis. Analysts expect that Walgreens will post $3.27 EPS for the current fiscal year.
A number of other analysts have also recently weighed in on WAG. Analysts at Zacks reiterated a “neutral” rating on shares of Walgreens in a research note to investors on Wednesday. They now have a $47.00 price target on the stock. Separately, analysts at Morgan Stanley reiterated an “equal weight” rating on shares of Walgreens in a research note to investors on Wednesday. Finally, analysts at Macquarie upgraded shares of Walgreens from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday.
One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and sixteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $49.13.
Walgreen Co (NYSE: WAG), together with its subsidiaries, operates the drugstore chain in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.